首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1454169

全球幽門螺旋桿菌診斷市場規模、佔有率、成長分析、最終用途、診斷測試、技術 - 產業預測，2024-2031 年

Global Helicobacter pylori H. pylori Diagnostics Market Size, Share, Growth Analysis, By End use(Hospital, Clinics), By Diagnostic Tests(Blood test, stool test), By Technology(Immuno diagnostic, Molecular diagnostic) - Industry Forecast 2024-2031

出版日期: 2024年03月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球幽門螺旋桿菌診斷市場規模估值為5.8768億美元，從2023年的6.23億美元成長到2031年的9.9372億美元，預計在預測期內成長(2024年-2031年)預計複合年成長率為6.01%。

幽門螺旋桿菌 (H. pylori) 診斷的日益普及代表著醫療保健領域的重要進步，可提供改進的診斷、有效的治療和降低成本。透過診斷檢測及時檢測病菌感染對於阻止疾病進展和最大限度地減少併發症起著至關重要的作用。這些測試可以準確識別胃和腸道中幽門螺旋桿菌的存在，使醫療保健專業人員能夠及時啟動適當的治療，最終改善患者的治療結果。早期療育不僅可以緩解症狀、加速潰瘍癒合，還可以降低胃癌等嚴重併發症的風險。幽門螺旋桿菌診斷市場上提供的各種非侵入性診斷選項，包括血液檢測、呼吸檢測和糞便抗原檢測，確保了患者的舒適度和可及性，同時保持了成本效益，從而將其適用性擴大到更多人。此外，從抗生素到降酸藥物等多種治療方法可為病菌感染提供高效的解決方案。透過有效處理這些感染疾病，患者不僅可以緩解症狀，還可以避免潰瘍和胃癌等潛在併發症，改善整體健康。有效的治療策略還可以作為預防措施，預防消化性潰瘍病的發生，消化性潰瘍病是與幽門螺旋桿菌相關的常見併發症，可最大程度地減少導致衰弱症狀和胃粘膜穿孔等嚴重後果的可能性。總體而言，幽門螺旋桿菌診斷和治療的一體化強調了向主動醫療管理的模式轉移，促進更好的健康結果和經濟效益。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Abbott Laboratories
Allergan plc
AstraZeneca plc
Bayer AG
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Halyard Health, Inc.
Hologic, Inc.
Merck & Co., Inc.
Mylan NV
Pfizer, Inc.
Quidel Corporation
Sanofi SA
Seegene Inc.
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech plc
ZEUS Scientific, Inc.

簡介目錄

Product Code: SQMIG35A2188

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 587.68 million in 2022 and is poised to grow from USD 623 million in 2023 to USD 993.72 million by 2031, growing at a CAGR of 6.01% during the forecast period (2024-2031).

The rise in popularity of Helicobacter pylori (H. pylori) diagnostics marks a significant advancement in healthcare, offering improved diagnosis, effective treatment, and cost reduction. Swift detection of H. pylori infections through diagnostic tests plays a pivotal role in halting disease progression and minimizing complications. These tests accurately identify the presence of the bacteria in the stomach or intestines, enabling timely initiation of appropriate treatment by healthcare providers, ultimately enhancing patient outcomes. Early intervention not only alleviates symptoms and accelerates ulcer healing but also mitigates the risk of severe complications, such as stomach cancer. The diverse array of non-invasive diagnostic options available in the H. pylori market, including blood, breath, and stool antigen tests, ensures patient comfort and accessibility while remaining cost-effective, thus extending their reach to a broader population. Furthermore, the plethora of treatment modalities, ranging from antibiotics to acid-reducing medications, offers highly efficacious solutions for combating H. pylori infections. By addressing these infections effectively, patients not only find relief from symptoms but also avert potential complications like ulcers and stomach cancer, thereby enhancing overall well-being. Effective treatment strategies also serve as a preventive measure against the development of peptic ulcers, a common complication associated with H. pylori, thus minimizing the occurrence of debilitating symptoms and serious outcomes like stomach lining perforation. Overall, the integration of H. pylori diagnostics and treatment underscores a paradigm shift towards proactive healthcare management, fostering better health outcomes and economic efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter pylori H. pylori Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter pylori H. pylori Diagnostics Market Segmental Analysis

Global Helicobacter pylori H. pylori Diagnostics market is segmented based on Diagnostic tests, technology, end-user, biomarker, and region. By end use, the Helicobacter pylori H. pylori Diagnostics Market is segmented into hospitals, clinics, research institutes, and others. By Diagnostic tests, the Helicobacter pylori H. pylori Diagnostics Market is segmented into Blood test, stool test, breath test, endoscopy, and others. By Technology, the Helicobacter pylori H. pylori Diagnostics Market is segmented into Immuno diagnostics, molecular diagnostics, Histology, and others. By region, the Helicobacter pylori H. pylori Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Helicobacter pylori H. pylori Diagnostics Market

The market for H. pylori thrives on the widespread prevalence of H. pylori infections worldwide, affecting an estimated half of the global population and ranking among the most prevalent bacterial infections. Consequently, there's an escalating demand for diagnostic tests and treatment solutions driven by the necessity for accurate diagnosis and effective management of the infection.

Restraints in the Global Helicobacter pylori H. pylori Diagnostics Market

The global market for H. pylori is buoyed by its widespread prevalence, with approximately half of the world's population affected by these infections, making it one of the most common bacterial infections globally. This prevalence fuels a growing demand for diagnostic tests and treatment options as healthcare systems strive to accurately diagnose and manage the infection effectively.

Market Trends of the Global Helicobacter pylori H. pylori Diagnostics Market

The market for H. pylori infection is experiencing a growing demand for non-invasive diagnostic methods like serology tests and urea breath tests. These alternatives are gaining popularity thanks to their minimal invasiveness and user-friendly design, driving a notable increase in their adoption.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Helicobacter pylori H. pylori Diagnostics Market by End use

Market Overview
Hospital
Clinics
research institutes and others

Global Helicobacter pylori H. pylori Diagnostics Market by Diagnostic Tests

Market Overview
Blood test
stool test
breath test
endoscopy and others

Global Helicobacter pylori H. pylori Diagnostics Market by Technology

Market Overview
Immuno diagnostic
Molecular diagnostic
Histology and others

Global Helicobacter pylori H. pylori Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halyard Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEUS Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments